Product Information
ASENAPINE 5 MG TABLET SL is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $2.0325 per EA under NDC 51991035860. Its NADAC has been published 286 times since Apr 14, 2021.
FDA first approved this application on Dec 10, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991035860
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Effective Date
9/23/2026
Active Ingredients
ASENAPINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA205960FDA Approved
12/10/2020
TE Code
AB
On Market Since
3/8/2021
Pharmacological Classes
Price Statistics
The NADAC for ASENAPINE 5 MG TABLET SL has been published 286 times since Apr 14, 2021, and over the history we have for it it has declined 50.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0325 per EA |
|---|---|
| All-time high | $6.2457 (May 12, 2021) |
| All-time low | $1.7475 (Nov 20, 2024) |
| 52-week high | $2.5136 |
| 52-week low | $2.0325 |
| Median price | $2.7766 |
| Average price | $2.9905 |
| Largest weekly change | +54.8% (Aug 18, 2021) |
| Weeks tracked | 286 |
| Tracking since | Apr 14, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ASENAPINE MALEATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Breckenridge Pharmaceutical Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ASENAPINE MALEATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ASENAPINE 5 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for ASENAPINE 5 MG TABLET SL, manufactured by Breckenridge Pharmaceutical Inc., is $2.0325 per EA (NDC 51991035860), effective Sep 30, 2026.
How has the price of ASENAPINE 5 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for ASENAPINE 5 MG TABLET SL has declined 50.6%. It has been tracked across 286 weekly CMS publications since Apr 14, 2021.
What are the highest and lowest recorded NADAC prices for ASENAPINE 5 MG TABLET SL?
Since Apr 14, 2021, the NADAC for ASENAPINE 5 MG TABLET SL has ranged from a low of $1.7475 (Nov 20, 2024) to a high of $6.2457 (May 12, 2021), with a median of $2.7766 per EA.
Are there cheaper alternatives to ASENAPINE 5 MG TABLET SL?
No other NADAC-published product currently shares the active ingredient and strength of ASENAPINE 5 MG TABLET SL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ASENAPINE 5 MG TABLET SL?
ASENAPINE 5 MG TABLET SL (NDC 51991035860) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.